AndroGel Buyer Seeks 2nd Shot At Pay-For-Delay Suit
By Brendan Pierson · March 8, 2010, 12:25 PM EST
An indirect purchaser of Solvay Pharmaceuticals Inc.'s testosterone supplement AndroGel has asked for leave to amend a recently dismissed putative class action accusing the drugmaker of keeping generics rivals out of...
To view the full article, register now.